Farallon Capital Management LLC Abb Vie Inc. Transaction History

Farallon Capital Management LLC

$19.9 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $29.6 Million - $35.5 Million	214,100 Added 29.53%	939,212 $152 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $29.5 Million - $33.8 Million	219,597 Added 43.44%	725,112 $97.3 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $88 Million - $112 Million	-639,152 Reduced 55.84%	505,515 $77.4 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $61.2 Million - $75.9 Million	-463,784 Reduced 28.83%	1,144,667 $186 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $121 Million - $153 Million	1,126,603 Added 233.81%	1,608,451 $218 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $71.1 Million - $80.7 Million	-668,152 Reduced 58.1%	481,848 $52 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $250 Million - $337 Million	-3,100,000 Reduced 72.94%	1,150,000 $123 Million
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $8.59 Million - $10.1 Million	100,000 Added 2.41%	4,250,000 $372 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $11 Million - $14.7 Million	150,000 Added 3.75%	4,150,000 $407 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $96.8 Million - $147 Million	1,500,000 Added 60.0%	4,000,000 $305 Million
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $108 Million - $135 Million	1,500,000 Added 150.0%	2,500,000 $221 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $63 Million - $75.7 Million	1,000,000 New	1,000,000 $75.7 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $64.4 Million - $86.2 Million	-700,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $10.3 Million - $11.3 Million	115,000 Added 19.66%	700,000 $67.7 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $40.9 Million - $52.2 Million	585,000	585,000 $52 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.

Account